Streetbeat News

KVAC

Keen Vision Acquisition Corporation Ordinary Shares

Industry

Shell Companies

Keen Vision Acquisition Corporation intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combination with one or more businesses or entities. It intends to focus on businesses in the biotechnology, consumer goods, and agriculture sectors. The company was incorporated in 2021 and is based in Summit, New Jersey.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Medera Inc. has published a study showcasing the use of AI and machine learning to enhance drug screening with human mini-heart technology. This approach aims to improve drug discovery efficiency, reduce costs, and enhance safety by leveraging AI/ML for better drug classification.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:07 pm

Medera, a biotechnology company, is set to merge with Keen Vision Acquisition Corporation (KVAC) and be listed on NASDAQ. The merger aims to accelerate Medera's clinical programs and is expected to close in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:17 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.